title: State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.
abstract: Three national surveys were conducted in 1991, 1997, and 2004 to evaluate state medical board members' knowledge and attitudes about prescribing opioid analgesics for pain management. Topics addressed include perceived legality of prolonged opioid prescribing, characteristics of addiction, prevalence of medication abuse and diversion, and perceived importance and influence of medical board policy. Questions were added in 2004 to determine board members' views about law enforcement involvement in physician investigations and prosecutions. This study assesses medical regulators' current beliefs and compares the 2004 responses with previous responses to determine how knowledge and attitudes about prescribing opioids have changed in recent years. Survey results show that board members have a greater understanding of pain management issues, particularly regarding characteristics of addiction and the legality of prolonged opioid prescribing for chronic noncancer pain. During the last 15 years, there has been substantial regulatory policy development, with medical boards adopting regulations, guidelines, or policy statements to provide guidance to licensees about using opioids to treat pain. However, many board members believe that federal and state law enforcement agencies have increased criminal investigations and prosecutions of physicians. We discuss appropriate regulatory and law enforcement responses to opioid prescribing violations, and suggest crucial next steps.
  
  
  CONCLUSIONS
  The authors examine the evolution of state medical board members' knowledge and attitudes about prescribing opioid analgesics to treat chronic pain, demonstrate that medical regulators believe that there have been increased criminal investigations and prosecutions of physicians for their prescribing practices, and suggest ways to avoid unwarranted criminal prosecutions.
authors.affiliation: Pain and Policy Studies Group, Comprehensive Cancer Center, University of Wisconsin, Madison, Wisconsin 53711-1068, USA. amgilson@wisc.edu
authors.forename: Aaron M
authors.initials: AM
authors.lastname: Gilson
authors.forename: Martha A
authors.initials: MA
authors.lastname: Maurer
authors.forename: David E
authors.initials: DE
authors.lastname: Joranson
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D001294:Attitude to Health; D002908:Chronic Disease; D002983:Clinical Competence; D003416:Criminal Law / Q000331:legislation & jurisprudence* / Q000639:trends; D004363:Drug Utilization; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence* / Q000639:trends; D035082:Federal Government; D006801:Humans; D008007:Licensure, Medical; D008875:Middle Aged; D009293:Opioid-Related Disorders / Q000517:prevention & control*; D010146:Pain / Q000188:drug therapy*; D018710:Pain Clinics / Q000331:legislation & jurisprudence / Q000592:standards; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D013044:Specialty Boards / Q000592:standards / Q000639:trends*; D013219:State Government; D011795:Surveys and Questionnaires; D014922:Wisconsin
chemical_list: D000701:Analgesics, Opioid